Both in Pharmaceuticals
Definium Therapeutics vs Arcutis Biotherapeutics
Over the past year DFTX returned +112.6% and ARQT returned +29.2%; their daily moves had a correlation of 0.30.
DFTX +112.6% ARQT +29.2%Growth of $1, one year, split-adjusted
| Metric | DFTX | ARQT |
|---|---|---|
| Price | $32.70 | $34.05 |
| Market cap | $4.39B | $4.28B |
| Today | −2.13% | +6.41% |
| 1 month | −8.2% | +42.3% |
| 6 months | +39.6% | +40.9% |
| Year to date | — | +17.3% |
| 1 year | — | +37.5% |
| Revenue growth (YoY) | — | +59.3% |
| Gross margin | — | 91.6% |
| Net margin | — | 11.6% |
| P/E (TTM) | — | 150.1× |
| Price / sales | — | 9.2× |
| Net cash | $1.05B | $129.7M |
| Dividend yield | — | — |
| Volatility (60d) | 56.9% | 54.8% |
| Short % of float | 7.6% | 18.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).